Katsuhiko Yamasaki, Tomonori Hasegawa, & Masatoshi Takeda. (2020). Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment‐resistant major depressive disorder. Wiley.
Chicago Style (17th ed.) CitationKatsuhiko Yamasaki, Tomonori Hasegawa, and Masatoshi Takeda. Serum Level of Soluble Interleukin 6 Receptor Is a Useful Biomarker for Identification of Treatment‐resistant Major Depressive Disorder. Wiley, 2020.
MLA (9th ed.) CitationKatsuhiko Yamasaki, et al. Serum Level of Soluble Interleukin 6 Receptor Is a Useful Biomarker for Identification of Treatment‐resistant Major Depressive Disorder. Wiley, 2020.
Warning: These citations may not always be 100% accurate.